Glimicord MP 1mg/500mg/15mg Tablet
Marketer
Cordial Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimicord MP 1mg/500mg/15mg Tablet
Metformin/Glimepiride/Pioglitazone 1mg/500mg/15mg tablets are a triple-combination medication designed to manage blood glucose. This therapy, used alongside a healthy diet and regular exercise, enhances blood sugar regulation in adult patients with type 2 diabetes. It promotes efficient insulin utilization, consequently reducing blood sugar. Dosage and regimen for Metformin/Glimepiride/Pioglitazone 1mg/500mg/15mg tablets must adhere to your physician's instructions. Administer with food to mitigate gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed one and resume your usual schedule. Never double the dose. An overdose can trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption as it may exacerbate side effects.
Uses of Glimicord MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimicord MP 1mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimicord MP 1mg/500mg/15mg tablet whole; do not crush, chew, or divide it. Administer this medicine with a meal.
Common Side effects of Glimicord MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimicord MP 1mg/500mg/15mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimicord MP 1mg/500mg/15mg tablet whole; do not fracture, pulverize, or chew it. Administer this medicine with a meal.
How Glimicord MP 1mg/500mg/15mg Tablet works:
Glimicord MP 1mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with distinct actions. This triple combination improves blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further boosts insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimicord MP 1mg/500mg/15mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimicord MP 1mg/500mg/15mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimicord MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimicord MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimicord MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Glimicord MP 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimicord MP 1mg/500mg/15mg Tablet :
Should you forget to take a Glimicord MP 1mg/500mg/15mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimicord MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently